| Product NDC: | 13267-123 |
| Proprietary Name: | Fludeoxyglucose F18 |
| Non Proprietary Name: | Fludeoxyglucose F18 |
| Active Ingredient(s): | 300 mCi/mL & nbsp; Fludeoxyglucose F18 |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13267-123 |
| Labeler Name: | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021870 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050819 |
| Package NDC: | 13267-123-23 |
| Package Description: | 17 mL in 1 VIAL, GLASS (13267-123-23) |
| NDC Code | 13267-123-23 |
| Proprietary Name | Fludeoxyglucose F18 |
| Package Description | 17 mL in 1 VIAL, GLASS (13267-123-23) |
| Product NDC | 13267-123 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fludeoxyglucose F18 |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20050819 |
| Marketing Category Name | NDA |
| Labeler Name | THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH |
| Substance Name | FLUDEOXYGLUCOSE F-18 |
| Strength Number | 300 |
| Strength Unit | mCi/mL |
| Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |